{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:38:09Z","timestamp":1792507089493,"version":"4.5.0"},"reference-count":59,"publisher":"Johns Hopkins School Bloomberg School of Public Health, Center for Communication Programs","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Glob Health Sci Pract"],"published-print":{"date-parts":[[2023,4,28]]},"DOI":"10.9745\/ghsp-d-22-00401","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:50:43Z","timestamp":1680288643000},"page":"e2200401","source":"Crossref","is-referenced-by-count":28,"title":["Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV"],"prefix":"10.9745","volume":"11","author":[{"given":"Theodore","family":"Ruel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Penazzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Zech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moherndran","family":"Archary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim R.","family":"Cressey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameena","family":"Goga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Harwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael J.","family":"Landovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Lain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lallemant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Namusoke-Magongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4690","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"2023091108301100000_11.2.e2200401.1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). In Danger: UNAIDS Global AIDS Update 2022. UNAIDS; 2022. Accessed March 6, 2023. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2022-global-aids-update_en.pdf"},{"key":"2023091108301100000_11.2.e2200401.2","unstructured":"Differentiated MCH Services: CQUIN Differentiated Maternal and Child Health Workshop. November 2020. Videocast available at: https:\/\/cquin.icap.columbia.edu\/event\/mch-workshop"},{"key":"2023091108301100000_11.2.e2200401.3","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Start Free, Stay Free, AIDS Free: Final Report on 2020 Targets. UNAIDS; 2021. Accessed March 6, 2023. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2021_start-free-stay-free-aids-free-final-report-on-2020-targets_en.pdf"},{"key":"2023091108301100000_11.2.e2200401.4","unstructured":"World Health Organization (WHO). HIV Diagnosis and ARV Use in HIV-Exposed Infants: A Programmatic Update. WHO; 2018. Accessed March 6, 2023. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/273155\/WHO-CDS-HIV-18.17-eng.pdf"},{"key":"2023091108301100000_11.2.e2200401.5","unstructured":"World Health Organization (WHO). Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach. WHO; 2021. Accessed March 6, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240031593"},{"key":"2023091108301100000_11.2.e2200401.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311801"},{"key":"2023091108301100000_11.2.e2200401.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)11046-2"},{"key":"2023091108301100000_11.2.e2200401.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010053431401"},{"key":"2023091108301100000_11.2.e2200401.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14538-2"},{"key":"2023091108301100000_11.2.e2200401.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811123392001"},{"key":"2023091108301100000_11.2.e2200401.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14341-3"},{"key":"2023091108301100000_11.2.e2200401.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08214-4"},{"key":"2023091108301100000_11.2.e2200401.13","doi-asserted-by":"publisher","DOI":"10.1086\/367898"},{"key":"2023091108301100000_11.2.e2200401.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033500"},{"key":"2023091108301100000_11.2.e2200401.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.7.794"},{"key":"2023091108301100000_11.2.e2200401.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2007.11.014"},{"key":"2023091108301100000_11.2.e2200401.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.2.189"},{"key":"2023091108301100000_11.2.e2200401.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801941"},{"key":"2023091108301100000_11.2.e2200401.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0911486"},{"key":"2023091108301100000_11.2.e2200401.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61653-X"},{"key":"2023091108301100000_11.2.e2200401.21","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001612"},{"key":"2023091108301100000_11.2.e2200401.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00984-8"},{"key":"2023091108301100000_11.2.e2200401.23","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000865"},{"key":"2023091108301100000_11.2.e2200401.24","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002350"},{"key":"2023091108301100000_11.2.e2200401.25","doi-asserted-by":"publisher","DOI":"10.1086\/314431"},{"key":"2023091108301100000_11.2.e2200401.26","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002294"},{"key":"2023091108301100000_11.2.e2200401.27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.828010"},{"key":"2023091108301100000_11.2.e2200401.28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix194"},{"key":"2023091108301100000_11.2.e2200401.29","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002871"},{"key":"2023091108301100000_11.2.e2200401.30","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz532"},{"key":"2023091108301100000_11.2.e2200401.31","unstructured":"McFarland EJ , Cunningham CK , Capparelli EV , et al . Safety and pharmacokinetics of monoclonal antibody, VRC01LS, in HIV-exposed newborns. Oral abstract 45. Presented at: CROI: Conference on Retroviruses and Opportunistic Infections; March 4\u20137, 2019; Seattle, WA. Accessed March 6, 2023. http:\/\/www.croiconference.org\/sessions\/safety-and-pharmacokinetics-monoclonal-antibody-vrc01ls-hiv-exposed-newborns"},{"key":"2023091108301100000_11.2.e2200401.32","unstructured":"World Health Organization (WHO). WHO Preferred Product Characteristics for Monoclonal Antibodies for HIV Prevention. WHO; 2022. Accessed March 6, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240045729"},{"key":"2023091108301100000_11.2.e2200401.33","unstructured":"World Health Organization (WHO). Updated Recommendations on HIV Prevention, Infant Diagnosis, Antiretroviral Initiation and Monitoring. WHO; 2021. Accessed March 6, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240022232"},{"key":"2023091108301100000_11.2.e2200401.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"2023091108301100000_11.2.e2200401.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101016"},{"key":"2023091108301100000_11.2.e2200401.36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab152"},{"key":"2023091108301100000_11.2.e2200401.37","unstructured":"Delany-Moretlwe S , Hughes J , Bock P , et al . Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: interim results from HPTN 084. Presented at: 4th International AIDS Society (IAS) HIV Research for Prevention Conference (HIVR4P); January 27\u201328, February 3\u20134, 2021; virtual. Accessed on March 6, 2023. https:\/\/programme.hivr4p.org\/Abstract\/Abstract\/1479"},{"key":"2023091108301100000_11.2.e2200401.38","unstructured":"Merck announces clinical holds on studies evaluating islatravir for the treatment and prevention of HIV-1 infection 2021. News release. Merck; December 13, 2021. Accessed March 6, 2023. https:\/\/www.merck.com\/news\/merck-announces-clinical-holds-on-studies-evaluating-islatravir-for-the-treatment-and-prevention-of-hiv-1-infection"},{"key":"2023091108301100000_11.2.e2200401.39","unstructured":"Merck to initiate new phase 3 clinical program with lower dose of daily oral islatravir in combination with doravirine for treatment of people with HIV-1 infection. News release. Merck; September 20, 2022. Accessed March 6, 2023. https:\/\/www.merck.com\/news\/merck-to-initiate-new-phase-3-clinical-program-with-lower-dose-of-daily-oral-islatravir-in-combination-with-doravirine-for-treatment-of-people-with-hiv-1-infection"},{"key":"2023091108301100000_11.2.e2200401.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031738"},{"key":"2023091108301100000_11.2.e2200401.41","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05190-0"},{"key":"2023091108301100000_11.2.e2200401.42","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002774"},{"key":"2023091108301100000_11.2.e2200401.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00570-5"},{"key":"2023091108301100000_11.2.e2200401.44","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab229"},{"key":"2023091108301100000_11.2.e2200401.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13972-y"},{"key":"2023091108301100000_11.2.e2200401.46","unstructured":"Treatment Action Group (TAG). Pipeline Report 2022: HIV Vaccines and Passive Immunization. TAG; 2022. Accessed March 6, 2023. https:\/\/www.treatmentactiongroup.org\/wp-content\/uploads\/2022\/07\/pipeline_HIV_vax_2022_final.pdf"},{"key":"2023091108301100000_11.2.e2200401.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.11.011"},{"key":"2023091108301100000_11.2.e2200401.48","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12397"},{"key":"2023091108301100000_11.2.e2200401.49","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-058347"},{"key":"2023091108301100000_11.2.e2200401.50","unstructured":"World Health Organization (WHO). Priorities for Antiretroviral Drug Optimization in Adults and Children: Report of a CADO, PADO and HIVResNeT Joint Meeting. WHO; 2021. Accessed March 13, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240053038"},{"key":"2023091108301100000_11.2.e2200401.51","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1386"},{"key":"2023091108301100000_11.2.e2200401.52","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00044-3"},{"key":"2023091108301100000_11.2.e2200401.53","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-246"},{"key":"2023091108301100000_11.2.e2200401.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00984-8"},{"key":"2023091108301100000_11.2.e2200401.55","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122010636"},{"key":"2023091108301100000_11.2.e2200401.56","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00266-6"},{"key":"2023091108301100000_11.2.e2200401.57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113249"},{"key":"2023091108301100000_11.2.e2200401.58","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30274-5"},{"key":"2023091108301100000_11.2.e2200401.59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225104"}],"container-title":["Global Health: Science and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9745\/GHSP-D-22-00401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T15:31:41Z","timestamp":1694446301000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ghspjournal.org\/lookup\/doi\/10.9745\/GHSP-D-22-00401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,4,28]]},"published-print":{"date-parts":[[2023,4,28]]}},"alternative-id":["10.9745\/GHSP-D-22-00401"],"URL":"https:\/\/doi.org\/10.9745\/ghsp-d-22-00401","relation":{},"ISSN":["2169-575X"],"issn-type":[{"value":"2169-575X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}